When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 63 Hits
  • Search Condition : Filter (MeSH = Liver Neoplasms / metabolism*)
Species Resource
DNA material P450 2B1 (CYP2B1) cDNA (RDB01245) Impaired nuclear translocation of CAR in hepatic preneoplastic lesions: association with an attenuated CYP2B induction by phenobarbital.
DNA material pCAG-HIVgp (RDB04394) , pCMV-VSV-G-RSV-Rev (RDB04393) , CSII-CMV-MCS (RDB04377). Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma.
Human and Animal Cells Decreased roundabout 1 expression promotes development of intrahepatic cholangiocarcinoma.
Human and Animal Cells Synergistic growth inhibition by acyclic retinoid and phosphatidylinositol 3-kinase inhibitor in human hepatoma cells.
Human and Animal Cells FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801.
Human and Animal Cells Tunicamycin potentiates cisplatin anticancer efficacy through the DPAGT1/Akt/ABCG2 pathway in mouse Xenograft models of human hepatocellular carcinoma.
Human and Animal Cells Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma.
Human and Animal Cells Efficient induction of apoptosis by wee1 kinase inhibition in hepatocellular carcinoma cells.
Human and Animal Cells MYC activates stem-like cell potential in hepatocarcinoma by a p53-dependent mechanism.
Human and Animal Cells Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma.
Human and Animal Cells Selective accumulation and growth inhibition of hybrid liposomes to human hepatocellular carcinoma cells in relation to fluidity of plasma membranes.
Human and Animal Cells Characterization of bridging integrator 1 (BIN1) as a potential tumor suppressor and prognostic marker in hepatocellular carcinoma.
Human and Animal Cells Rapid downregulation of cyclin D1 induced by geranylgeranoic acid in human hepatoma cells.
Human and Animal Cells Differential expression of TRPM7 in rat hepatoma and embryonic and adult hepatocytes.
Human and Animal Cells Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma.
Human and Animal Cells Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib.
Human and Animal Cells Cystine/glutamic acid transporter is a novel marker for predicting poor survival in patients with hepatocellular carcinoma.
Human and Animal Cells Selective protection of human liver tissue in TNF-targeting of cancers of the liver by transient depletion of adenosine triphosphate.
Human and Animal Cells Tumor-associated macrophage promotes tumor progression via STAT3 signaling in hepatocellular carcinoma.
Human and Animal Cells Expression of cytokeratin 19 in human hepatocellular carcinoma cell lines.